30 closest matches · ranked by relevance
Standard Treatment Versus Engagement Focused Treatment
Primary: Subjective Quality of Life — 3.9; 3.8; 4.3; 4.0 units on a scale
Schizophrenia Spectrum & Other Psychotic Disorders
Primary: Provision of Appropriate Preventive and Medical Treatments — 144; 117; 146; 131 Participants
Post Traumatic Stress Disorder · Schizophrenia · Schizoaffective Disorder
Primary: Posttraumatic Stress Disorder (PTSD) Checklist (PCL) — 66.94; 66.33; 51.20; 60.60 score on a scale
Mental Disorder
Primary: Change in Levels of Aggression Score From Baseline to Month 3 — -4.81; -2.68 score on a scale
Depression · Bipolar Disorder · Anxiety Disorders
Primary: Clinical Global Improvement Scale (CGIS) — 14; 20 Participants
Diabetes Mellitus · Bipolar Disorder · Depression
Primary: Brief Psychiatric Rating Scale (BPRS) at 60 Weeks — 32.04; 35.89 scores on a scale — p=.785
Bipolar Disorder · Schizophrenia · Major Depressive Disorder
Primary: Physical Health-related Quality of Life — 34.00; 33.61 units on a scale
Schizophrenia · Bipolar Disorder · Psychotic Disorders
Primary: Bell-Lysaker Emotion Recognition Task Total Score — 14.8; 16.00 score on a scale — p=.08
Epilepsy · Schizophrenia · Schizoaffective Disorder
Primary: Change in Montgomery Asberg Depression Rating Scale (MADRS) — 16.75; 22.94; 11.21; 21.81 score on a scale — p=0.036
Schizophrenia · Bipolar Disorder · Schizoaffective Disorder
Primary: Feasibility of Passive Self-tracking of Mental Health — 58 Participants
Schizophrenia · Bipolar Disorder
Primary: Score on the Brief Psychiatric Rating Scale (BPRS) — 43.2; 41.6; 42.0; 41.0 units on a scale
Mental Illness · Chronic Disease
Primary: Number of Participants Who Received COVID-19 Vaccine — 56; 50 Participants
Chronic Disease · Mental Health · Behavioral Health
Primary: Change in Patient Activation in Care (PAM, a 13-item Scale) — 56.99; 56.77; 56.84; 58.74 units on a scale — p=<0.0001
Mental Disorders
Primary: Impairment (Sheehan Disability Scale) — 14.30; 12.03; 11.76; 6.57 score on a scale — p=0.025
Schizophrenia · Depression · Medical Disorders
Primary: Changed Score on SF-12 Pain Items From Baseline to 6 Months and 12 Months — -.16; .11; .19; -.18 Changed mean z-score — p=.073
Schizophrenia · Bipolar Disorder · Major Depressive Disorder
Primary: Alcohol Use Assessed by Ethyl Glucuronide (EtG) Detection in Urine — 0.66; 0.65; 0.61 proportion uEtG negative
Chronic Disease · Mental Disorder · Health Behavior
Primary: Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke — 14.2; 20.8 percentage of annual rate of change
Mental Illness · Chronic Medical Illness
Primary: Short Form-12 (SF-12) General Health (Norm Based) — 40.4; 38.9; 42.5; 41.6 units on a scale — p=0.362
Alcohol Abuse · Schizophrenia · Bipolar Disorder
Primary: Alcohol Use as Assessed by Ethyl Glucuronide Detection in Urine — 408.86; 734.79 EtG Value (nanograms per milileter)
Smoking Cessation · Cigarette Smoking · Schizophrenia
Primary: 7-Day Point Prevalence Abstinence — 5; 3; 4; 5 Participants
Schizophrenia · Schizo-affective Disorder
Primary: Illness Management Ratings — 3.5; 3.3; 3.5; 3.6 units on a scale — p=.8868
Cigarette Smoking · Schizophrenia · Bipolar Disorder
Primary: Number of Participants Who Are Abstinent at the Intervention Year 2 Assessment in Cohort 1 — 13; 32; 19 Participants — p=0.013
Obesity · Mental Disorder
Primary: Weight — 226.54; 225.46; 218.19; 225.63 pounds (lbs) — p=.025
Sleep Disorder · Circadian Dysregulation
Primary: Patient-level Outcome: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance — 63.86; 62.10; 62.81; 62.80 T-score — p=<0.001
Cardiovascular Risk Factors · Serious Mental Illness
Primary: Global Framingham Risk Score — 11.5; 12.7; 9.9; 12.3 score on a scale
Mood Disorder · Mental Disorder Diagnosed in Childhood · Attention Deficit and Disruptive Behavior Disorder
Primary: Percentage of Participants That "Much Improved" (Score of 2) in, or "Completely Recovered" (Score of 1) From Their Irritability Severity, as Measured With the Clinical…
Intellectual Disability · Developmental Disability · Axis I Diagnosis
Primary: New COVID-19 Group Home Incidence — 1.61; 1.40; 0.16; 0.09 New COVID-19 cases per 100 person-months — p=0.89
Schizophrenia · Bipolar Disorder · Schizo Affective Disorder
Primary: Working Memory Capacity Composite Score — .64; .70; .64; .72 Proportion of correct responses — p== .69
Tobacco Smoking · Psychiatric Disorder · Psychiatric Hospitalization
Primary: Feasibility of Recruitment: Proportion of Smokers Seen During the Partial Hospital Visit Who Enroll in the Study — 17 Participants
Mental Disorders, Severe · Schizophrenia and Related Disorders · Bipolar Disorder
Primary: Number of Inpatient Psychiatric Stays for Intervention and Control Participants — 1.9; 2.3 Hospitalizations